Aug 2026
CAR T cell-derived TNF is an early determinant of cytokine release syndrome severity.
Cytokine release syndrome (CRS) is a common and potentially severe toxicity of chimeric antigen receptor (CAR) T cell therapy, characterized by activation of the host myeloid compartment and systemic inflammation. Although downstream effectors such as interleukin-6 (IL-6) and IL-1β are well-characterized, the upstream...
P. Lindenbergh, Theodoros Giavridis, Ophélie Vivier et al.
· Science immunology · 2 citations